CDC Level 2 Alert: Bundibugyo Ebola Outbreak in DRC and Uganda

CDC Level 2: Bundibugyo Virus Disease in DRC and Uganda

On 28 August 2026, the U.S. Centers for Disease Control and Prevention published a Level 2 (Practice Enhanced Precautions) travel health notice covering the Democratic Republic of the Congo and Uganda. The notice relates to an ongoing outbreak of Bundibugyo virus disease (BVD), caused by one of the orthoebolaviruses within the Ebola disease family.

What the notice says

  • Enhanced precautions are recommended for travel to Uganda and to DRC provinces not affected by the current outbreak.
  • Travel to outbreak-affected areas carries higher risk, and CDC's guidance for those areas is more restrictive; travelers should consult the primary notice before planning itineraries.
  • Level 2 is an advisory tier, not a travel ban. It signals that specific behavioral precautions meaningfully reduce risk.

How Ebola-family viruses spread

Transmission occurs through direct contact with blood or body fluids of a person who is sick with or has died from the disease, contaminated objects such as needles and linens, and certain infected animals including fruit bats and non-human primates. It is not spread through casual airborne contact in the way respiratory viruses are. Symptoms typically begin 2–21 days after exposure and may include fever, severe headache, muscle pain, fatigue, gastrointestinal symptoms, and in later stages unexplained bleeding or bruising.

General precautions described in public health guidance

  • Avoid contact with sick people, bodily fluids, and human remains, including funeral or burial rituals.
  • Avoid contact with bats, non-human primates, and raw or undercooked bushmeat.
  • Avoid non-essential visits to healthcare facilities in affected areas.
  • Practice frequent hand hygiene.
  • Monitor your health for 21 days after departure and seek care immediately if symptoms develop, informing clinicians of your travel history.

Pharmacist's note: Two points often get overlooked. First, the licensed Ebola vaccines target Zaire ebolavirus; cross-protection against the Bundibugyo species should not be assumed, so vaccination status is not a substitute for behavioral precautions. Discuss eligibility and limitations with a travel health clinician rather than assuming coverage. Second, early Ebola symptoms are indistinguishable from malaria, typhoid, dengue, and common gastroenteritis — all far more statistically likely in this region. Self-treating a fever with leftover antibiotics or antimalarials from a home medicine cabinet can delay diagnosis of either condition. Carry documentation of your routine medications, and if you develop fever during or within 21 days after travel, contact health services by phone first so appropriate precautions can be arranged.

Where to verify

Outbreak boundaries and affected provinces change. Consult the CDC travel notice and your national travel health authority close to departure for the current status.

This is a public-information summary and does not constitute medical advice or treatment recommendations.

Primary sources

PharmTrip may include promotional content. Products and services are independently evaluated by a licensed pharmacist and rankings are never altered by advertiser requests. Information reflects what was current at the time of writing — please verify the latest terms on each provider's official site.